drugset / Trial / NCT00277017
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate a therapy combining the established FUNIL regimen with Thalidomide. We want to see how well the therapy works, if it can be easily done, and how well the body handles the treatment. We also wish to see if the addition of Thalidomide will increase the effectiveness of the already established treatment regimen.
Timeline
- Start
- 2000-09
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | 1200 mg | Oral |
| Background | Interferon-α | Protein / enzyme biologic | — | Subcutaneous |
| Background | aldesleukin | Protein / enzyme biologic | — | Intravenous |
| Background | fluorouracil | Small molecule | — | Intravenous |